249 related articles for article (PubMed ID: 31980336)
1. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
Li CW; Osman R; Menconi F; Concepcion E; Tomer Y
J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
[TBL] [Abstract][Full Text] [Related]
2. Tg.2098 is a major human thyroglobulin T-cell epitope.
Menconi F; Huber A; Osman R; Concepcion E; Jacobson EM; Stefan M; David CS; Tomer Y
J Autoimmun; 2010 Aug; 35(1):45-51. PubMed ID: 20303712
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
Pichurin P; Pham N; David CS; Rapoport B; McLachlan SM
Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
[No Abstract] [Full Text] [Related]
5. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
[TBL] [Abstract][Full Text] [Related]
6. Effective Inhibition of Thyroid Antigen Presentation Using Retro-Inverso Peptides in Experimental Autoimmune Thyroiditis: A Pathway Toward Immune Therapies of Thyroid Autoimmunity.
Li CW; Osman R; Menconi F; Hou H; Schechter C; Kozhakhmetova A; Tomer Y
Thyroid; 2023 Apr; 33(4):492-500. PubMed ID: 36762945
[No Abstract] [Full Text] [Related]
7. Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b.
Pichurin P; Chen CR; Pichurina O; David C; Rapoport B; McLachlan SM
Thyroid; 2003 Oct; 13(10):911-7. PubMed ID: 14611699
[TBL] [Abstract][Full Text] [Related]
8. The role of glutamic or aspartic acid in position four of the epitope binding motif and thyrotropin receptor-extracellular domain epitope selection in Graves' disease.
Inaba H; Martin W; Ardito M; De Groot AS; De Groot LJ
J Clin Endocrinol Metab; 2010 Jun; 95(6):2909-16. PubMed ID: 20392871
[TBL] [Abstract][Full Text] [Related]
9. Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis.
Li CW; Menconi F; Osman R; Mezei M; Jacobson EM; Concepcion E; David CS; Kastrinsky DB; Ohlmeyer M; Tomer Y
J Biol Chem; 2016 Feb; 291(8):4079-90. PubMed ID: 26703475
[TBL] [Abstract][Full Text] [Related]
10. Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides.
Inaba H; Moise L; Martin W; De Groot AS; Desrosiers J; Tassone R; Buchman G; Akamizu T; De Groot LJ
Endocrinology; 2013 Jun; 154(6):2234-43. PubMed ID: 23592747
[TBL] [Abstract][Full Text] [Related]
11. Cepharanthine Blocks Presentation of Thyroid and Islet Peptides in a Novel Humanized Autoimmune Diabetes and Thyroiditis Mouse Model.
Li CW; Osman R; Menconi F; Faustino LC; Kim K; Clarke OB; Hou H; Tomer Y
Front Immunol; 2021; 12():796552. PubMed ID: 34987519
[TBL] [Abstract][Full Text] [Related]
12. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y
J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice.
Jansson L; Vrolix K; Jahraus A; Martin KF; Wraith DC
Endocrinology; 2018 Sep; 159(9):3446-3457. PubMed ID: 30099489
[TBL] [Abstract][Full Text] [Related]
14. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain.
Soliman M; Kaplan E; Yanagawa T; Hidaka Y; Fisfalen ME; DeGroot LJ
J Clin Endocrinol Metab; 1995 Mar; 80(3):905-14. PubMed ID: 7533773
[TBL] [Abstract][Full Text] [Related]
15. Immune response of mice transgenic for human histocompatibility leukocyte Antigen-DR to human thyrotropin receptor-extracellular domain.
Inaba H; Pan D; Shin YH; Martin W; Buchman G; De Groot LJ
Thyroid; 2009 Nov; 19(11):1271-80. PubMed ID: 19725778
[TBL] [Abstract][Full Text] [Related]
16. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule.
Sawai Y; DeGroot LJ
J Clin Endocrinol Metab; 2000 Mar; 85(3):1176-9. PubMed ID: 10720058
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor.
Arima T; Shimojo N; Yamaguchi K; Tomiita M; Kohn LD; Kohno Y
Clin Immunol; 2008 Apr; 127(1):7-13. PubMed ID: 18234558
[TBL] [Abstract][Full Text] [Related]
19. Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves' disease.
Kuang M; Wang S; Wu M; Ning G; Yao Z; Li L
Mol Cell Endocrinol; 2010 May; 319(1-2):23-9. PubMed ID: 20015465
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.
Deshmukh US; Sim DL; Dai C; Kannapell CJ; Gaskin F; Rajagopalan G; David CS; Fu SM
J Autoimmun; 2011 Nov; 37(3):254-62. PubMed ID: 21868195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
